Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Incorporating alternative investments into your long-term portfolio can enhance diversification and improve returns.
27,567 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Freshworks stock sinking today signals evolving investor concerns about growth, profitability, and competition. This ...
A large institutional stake in Enviri sparks questions about the company’s trajectory. This article breaks down what ...
Two rising names—Oklo and Centrus Energy—are shaping the future of U.S. nuclear energy. This guide breaks down which ...
Oil headlines have surged, but MPLX has moved differently. This article breaks down two critical takeaways for invest...
When a magnificent dividend stock drops 8%, it can feel painful. This guide shows how to separate price swings from l...
Earnings season often brings volatility, but a post-earnings sell-off could incredible offer a rare entry point for p...
Icon stock crushed Wednesday as the CRO leader posted a stronger quarter than expected. We break down what drove the ...
Growing families bring new expenses and new priorities. This guide uses lessons from celebrity headlines—especially j...
Surviving a brain injury is only the first step. This guide explains how to plan finances for medical bills, recovery...
A mounting deficit of $3.4 trillion is shaping long-term borrowing costs, with the 30-year fixed mortgage lingering n...
With crude hovering near $70, some investors wonder if energy stocks can keep delivering. This article explains why t...